181 related articles for article (PubMed ID: 25934694)
1. Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal Carcinogenesis.
Cheasley D; Pereira L; Sampurno S; Sieber O; Jorissen R; Xu H; Germann M; Yuqian Y; Ramsay RG; Malaterre J
Mol Cancer Res; 2015 Aug; 13(8):1185-96. PubMed ID: 25934694
[TBL] [Abstract][Full Text] [Related]
2. Myb controls intestinal stem cell genes and self-renewal.
Cheasley D; Pereira L; Lightowler S; Vincan E; Malaterre J; Ramsay RG
Stem Cells; 2011 Dec; 29(12):2042-50. PubMed ID: 21997934
[TBL] [Abstract][Full Text] [Related]
3. Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression.
Zhang T; Nanney LB; Peeler MO; Williams CS; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
Cancer Res; 1997 May; 57(9):1638-43. PubMed ID: 9134999
[TBL] [Abstract][Full Text] [Related]
4. Ccne1 Overexpression Causes Chromosome Instability in Liver Cells and Liver Tumor Development in Mice.
Aziz K; Limzerwala JF; Sturmlechner I; Hurley E; Zhang C; Jeganathan KB; Nelson G; Bronk S; Fierro Velasco RO; van Deursen EJ; O'Brien DR; Kocher JA; Youssef SA; van Ree JH; de Bruin A; van den Bos H; Spierings DCJ; Foijer F; van de Sluis B; Roberts LR; Gores GJ; Li H; van Deursen JM
Gastroenterology; 2019 Jul; 157(1):210-226.e12. PubMed ID: 30878468
[TBL] [Abstract][Full Text] [Related]
5. miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1).
Han Z; Zhang Y; Yang Q; Liu B; Wu J; Zhang Y; Yang C; Jiang Y
Oncotarget; 2015 May; 6(15):13149-63. PubMed ID: 25909221
[TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression.
Yang L; Fang D; Chen H; Lu Y; Dong Z; Ding HF; Jing Q; Su SB; Huang S
Oncotarget; 2015 Aug; 6(25):20801-12. PubMed ID: 26204491
[TBL] [Abstract][Full Text] [Related]
7. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
8. Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients.
Zhang T; Nanney LB; Luongo C; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
Cancer Res; 1997 Jan; 57(1):169-75. PubMed ID: 8988060
[TBL] [Abstract][Full Text] [Related]
9. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR
Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863
[TBL] [Abstract][Full Text] [Related]
10. AURKB promotes colorectal cancer progression by triggering the phosphorylation of histone H3 at serine 10 to activate CCNE1 expression.
Li L; Xie K; Xie H; Wang L; Li Z; Lu Q; Feng J
Aging (Albany NY); 2024 May; 16(9):8019-8030. PubMed ID: 38713155
[TBL] [Abstract][Full Text] [Related]
11. Prdm5 suppresses Apc(Min)-driven intestinal adenomas and regulates monoacylglycerol lipase expression.
Galli GG; Multhaupt HA; Carrara M; de Lichtenberg KH; Christensen IB; Linnemann D; Santoni-Rugiu E; Calogero RA; Lund AH
Oncogene; 2014 Jun; 33(25):3342-50. PubMed ID: 23873026
[TBL] [Abstract][Full Text] [Related]
12. Rsf-1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development.
Sheu JJ; Choi JH; Guan B; Tsai FJ; Hua CH; Lai MT; Wang TL; Shih IeM
J Pathol; 2013 Mar; 229(4):559-68. PubMed ID: 23378270
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes.
Noske A; Henricksen LA; LaFleur B; Zimmermann AK; Tubbs A; Singh S; Storz M; Fink D; Moch H
Exp Mol Pathol; 2015 Feb; 98(1):47-54. PubMed ID: 25527175
[TBL] [Abstract][Full Text] [Related]
14. Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression.
Chen L; Wei T; Si X; Wang Q; Li Y; Leng Y; Deng A; Chen J; Wang G; Zhu S; Kang J
J Biol Chem; 2013 May; 288(20):14510-14521. PubMed ID: 23543735
[TBL] [Abstract][Full Text] [Related]
15. Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.
Duan Y; Tian L; Gao Q; Liang L; Zhang W; Yang Y; Zheng Y; Pan E; Li S; Tang N
Oncotarget; 2016 Jul; 7(29):45863-45875. PubMed ID: 27351279
[TBL] [Abstract][Full Text] [Related]
16. c-Myb is required for progenitor cell homeostasis in colonic crypts.
Malaterre J; Carpinelli M; Ernst M; Alexander W; Cooke M; Sutton S; Dworkin S; Heath JK; Frampton J; McArthur G; Clevers H; Hilton D; Mantamadiotis T; Ramsay RG
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3829-34. PubMed ID: 17360438
[TBL] [Abstract][Full Text] [Related]
17. Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance.
Srivastava SK; Bhardwaj A; Singh S; Arora S; McClellan S; Grizzle WE; Reed E; Singh AP
Carcinogenesis; 2012 Jun; 33(6):1149-57. PubMed ID: 22431717
[TBL] [Abstract][Full Text] [Related]
18. [miR-497 suppresses proliferation of human cervical carcinoma HeLa cells by targeting cyclin E1].
Han J; Huo M; Mu M; Liu J; Zhang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):597-600. PubMed ID: 24909281
[TBL] [Abstract][Full Text] [Related]
19. PKMYT1: A Potential Target for CCNE1 Amplificated Colorectal Tumors.
Fang Y; Zhang X; Guo Y; Dong Y; Liu W; Hu X; Li X; Gao D
Cell Biochem Biophys; 2023 Sep; 81(3):569-576. PubMed ID: 37572218
[TBL] [Abstract][Full Text] [Related]
20. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
Sonntag R; Giebeler N; Nevzorova YA; Bangen JM; Fahrenkamp D; Lambertz D; Haas U; Hu W; Gassler N; Cubero FJ; Müller-Newen G; Abdallah AT; Weiskirchen R; Ticconi F; Costa IG; Barbacid M; Trautwein C; Liedtke C
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9282-9287. PubMed ID: 30150405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]